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Abstract
Background: The pathophysiology of coronary artery dissection (CD) remains poorly under-
stood and little is known about the factors predicting mortality in these patients. We aimed to 
study the epidemiology of CD and predictors of mortality in these patients.
Methods: All patients diagnosed with CD in the Nationwide Inpatient Sample 2009–2010 
database using International Classification of Diseases ninth revision 414.12 were included 
in the study. Chronic conditions included in the analysis were diabetes mellitus, hypertension, 
hyperlipidemia, coronary artery disease (CAD), obesity, alcohol use, smoking, heart failure 
and ventricular arrhythmias. Non-cardiovascular conditions were connective tissue disorders, 
fibromuscular dysplasia, Ehlers-Danlos syndrome, Marfan’s syndrome, sarcoidosis, Crohn’s 
disease, polycystic kidney disease, rheumatoid arthritis, vasculitis including giant cell arteritis, 
polyarteritis nodosa and Takayasu’s disease, cocaine use, early or premature labor.
Results: The prevalence of CD in the United States was 0.02% (n = 11,255), based on the 
hospital admissions reviewed in the database. The mean age was 63.25 years with women 
(64.62 years) being older than men (62.25 years) (p < 0.001). In-hospital mortality rate was 
4.2%, with women (5.5%) having higher mortality than men (3.2%) (p = 0.009). Ventricular 
arrhythmias (OR 5.86, p < 0.001) predicted higher mortality, while hyperlipidemia (OR 0.26, 
p < 0.001) and CAD (OR 0.31, p = 0.001) predicted lower mortality in multivariate analysis.
Conclusions: Our study demonstrated that CD was more prevalent in men but women had 
higher mortality than men. Age, heart failure and ventricular arrhythmias were independent 
predictors of increased mortality but hyperlipidemia CAD predicted lower mortality in patients 
with CD. (Cardiol J 2015; 22, 2: 135–140)
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Introduction
Coronary artery dissection (CD) is rare with 
a prevalence of 0.07% to 1.1%. The first case of 
CD was reported in 1931 [1] and about 440 cases 
of spontaneous coronary artery dissection (SCD) 
have been reported in the literature since then 
[2]. It is characterized by separation of the coro-
nary arterial wall due to bleeding within the wall 
either from an intimal tear or a medial hematoma 
[3, 4]. Both processes result in compromised flow 
either from multiple lumens or flaps in the case 
of an intimal tear or luminal narrowing from the 
intramural hematoma, resulting in compromised 
antegrade blood flow. The clinical presentation is 
that of an acute coronary syndrome (ACS) which 
includes angina, non-ST elevation myocardial 
infarction (NSTEMI) or ST-segment elevation 
myocardial infarction (STEMI) and ventricular fi-
brillation and/or sudden cardiac death [5–7]. CD can 
be SCD, traumatic (as a complication of coronary 
angiography) [8, 9], and either atherosclerotic or 
non-atherosclerotic. Non-atherosclerotic SCD is 
associated with fibromuscular dysplasia (FMD), 
inflammatory and connective tissue disorders, 
emotional stress, exertion, post partum state and 
is more common in younger women [3, 4, 10]. 
Typically CD involves a single coronary artery, 
however multi vessel coronary artery dissection 
has also been reported [3].
CD and especially SCD remain under diag-
nosed and the pathophysiology is still poorly un-
derstood. The reasons include under recognition 
of CD as a cause of STEMI and arrhythmia related 
sudden cardiac death, misdiagnosis of chest pain 
in younger females with SCD as non-cardiac chest 
pain and incorrectly characterizing an intramural 
hematoma as spasm or atherosclerotic plaque dur-
ing angiography. In addition little is known about 
the factors predicting mortality in CD, which till 
now were largely limited to case reports and small 
case series. The objective of our analysis was to 
determine the epidemiology and predictors of 
mortality in patients with CD.
Methods
We accessed the Nationwide Inpatient Sample 
(NIS) database for the period 2009 to 2010 from 
the Healthcare Cost and Utilization Project of the 
Agency for Healthcare Research and Quality, in 
Rockville, MD. It is the largest all-payer hospitaliza-
tion database representing up to 8 million hospital 
stays from 1,000 hospitals in the United States. The 
data represents 20% of all inpatient admissions to 
non-federal hospitals in the United States. All pa-
tients with primary and all listed diagnoses of CD 
in the NIS 2009–2010 database using International 
Classification of Diseases 9 (ICD-9) 414.12 were in-
cluded in the study. As the ICD-9 code was restricted 
only to the diagnosis of CD and no other codes exist, 
the type of CD (spontaneous, atherosclerotic, non-
atherosclerotic or iatrogenic) was uncertain. All 
hospitalizations of any patient aged 18 years or older 
were included in the analysis. Age was represented 
as a continuous variable while race was categorized 
as white, black, Asian, Hispanic, native American or 
others. We weighted hospital and discharge data to 
generate national estimates.
Outcomes
The primary outcomes of our study were 
predictors and prevalence of in-hospital mortality. 
We assessed the demographics and the preva-
lence of chronic conditions in patients with CD. 
Chronic conditions included diabetes mellitus, 
hypertension, hyperlipidemia, obesity, coronary 
artery disease (CAD), smoking and alcohol use. 
Non-cardiovascular conditions analyzed were con-
nective tissue disorders, fibromuscular dysplasia, 
Ehlers-Danlos syndrome, Marfan’s syndrome, sar-
coidosis, Crohn’s disease, cocaine use, polycystic 
kidney disease, rheumatoid arthritis, vasculitis 
including giant cell arteritis, polyarteritis nodosa 
and Takayasu’s disease and early or premature 
labor. We also determined the prevalence of heart 
failure (HF) and ventricular arrhythmia (refer to 
supplement for ICD-9 codes used).
Statistical analysis
We analyzed the database from 2009 to 2010. 
Categorical variables were represented as per-
centages (%), while continuous variables were 
represented as mean ± standard deviation. Uni-
variate regression analysis was done to determine 
predictors of mortality in CD. Including traditional 
risk factors and other factors that predicted mor-
tality in univariate analysis, stepwise multimodel 
logistic regression was performed. A p value less 
than 0.05 was considered statistically significant. 
All statistical analysis was performed using STATA 
10.0, Statacorp, College Station, TX. The study 
did not have any outside sponsorship or funding.
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Results
Demographics
The prevalence of CD was 0.02% (n = 11,255) 
of all hospital admissions reviewed during the year 
2009–2010 in United States and was higher in men 
(57.7%) compared to women (42.3%). The mean 
age was 63.3 years, women were older than men 
(64.6 years vs. 62.3 years; p < 0.001), the mean 
length of stay was 4.5 days and women stayed 
longer than men (4.9 vs. 4.1 days; p = 0.001). 
Chronic conditions prevalent in our study were 
CAD (92%), hypertension (70%), hyperlipidemia 
(64%), diabetes mellitus (30%) and smoking (22%). 
Connective tissue disorders (0.4%), sarcoidosis 
(0.2%), Crohn’s disease (0.1%), rheumatoid ar-
thritis (1%), fibromuscular dysplasia (0.1%), giant 
cell arteritis (0.05%), polycystic kidney disease 
(0.05%) and Marfan’s syndrome (0.04%) were 
the non-cardiovascular conditions included in our 
analysis (Table 1).
Primary and secondary outcomes
In the 11,255 hospital admissions of CD the 
overall in-patient mortality rate was 4.2%, HF rate 
was present in 16% and ventricular arrhythmias 
were present in 11% of this population. Women 
compared to men, had higher mortality (5.5% vs. 
3.2%, respectively, p = 0.008), more HF (19% vs. 
14%, respectively, p = 0.001) but less ventricular 
arrhythmia (9% vs. 12% in women, p = 0.007) 
(Table 1).
We also analyzed the association of various 
risk factors and comorbidities in predicting mor-
tality in patients with CD. In unadjusted analysis, 
age (odds ratio [OR] 1.03, 95% confidence interval 
[CI] 1.01–1.05, p < 0.001), female sex (OR 1.74, 
95% CI 1.15–2.64, p = 0.009), HF (OR 2.68, 95% 
CI 1.71–4.21, p < 0.001) and ventricular arrhyth-
mias (OR 6.01, 95% CI 3.85–9.34, p < 0.001) were 
associated with increased mortality in patients 
with CD. Interestingly, hyperlipidemia (OR 0.24, 
95% CI 0.15–0.37, p < 0.001) and CAD (OR 0.34, 
95% CI 0.20–0.58, p < 0.001) had an inverse 
relationship in predicting mortality (Table 2). 
Gender-specific analysis showed hyperlipidemia 
and ventricular arrhythmia predicted mortality 
in both men and women. However, age (OR 1.04, 
95% CI 1.01–1.067, p = 0.003) and HF (OR 3.10, 
95% CI 1.72–5.59, p < 0.001) predicted mortal-
Table 1. Baseline demographic and clinical characteristics stratified by gender.
Variable* Total
(n = 11,255)
Males
(n = 6,498)
Females
(n = 4,757)
P**
Age 63.3 ± 0.3 62.3 ± 0.3 64.6 ± 0.5 < 0.001
Length of stay 4.5 ± 0.1 4.1 ± 0.1 4.9 ± 0.2 0.001
Mortality 4.2 3.2 5.5 0.008
Diabetes 30 28 33 0.02
Hypertension 70 69 71 0.21
Hyperlipidemia 64 65 63 0.39
Obesity 13 12 15 0.03
Coronary artery disease 92 94 90 0.006
Smoking 22 25 19 0.002
Alcohol 2 3 0.8 < 0.001
Heart failure 16 14 19 0.001
Ventricular arrhythmia 11 12 9 0.007
Cocaine use 0.5 0.6 0.3 0.27
Crohn’s disease 0.1 0.2 0.1 0.68
Connective tissue disorder 0.4 0.2 0.7 0.12
Fibro muscular dysplasia 0.1 0.2 0.1 0.76
Marfan’s syndrome 0.04 0.07 – 0.39
Sarcoidosis 0.2 0.2 0.3 0.37
Rheumatoid arthritis 1 0.8 1.2 0.54
Giant cell arteritis 0.05 – 0.11 0.24
Polycystic kidney disease 0.05 0.09 – 0.39
*Continuous variables are expressed as median (IQR). Categorical variables are expressed as %; **Pearson’s c2 for categorical; linear regression 
for continuous variables.
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ity only in females and CAD was associated with 
decreased mortality only in males (OR 0.24, 95% 
CI 0.11–0.52, p < 0.001) (Table 2).
Stepwise multimodel logistic regression showed 
that age (OR 1.03, 95% CI 1.01–1.05, p = 0.001), ven-
tricular arrhythmias (OR 5.86, 95% CI 3.30–10.41, 
p < 0.001) and HF (OR 1.89, 95% CI 1.14–3.13, 
p = 0.014) were independently associated with 
increased mortality after adjusting for demographic 
factors, traditional cardiovascular and non-cardio-
vascular risk factors (Table 3). Hyperlipidemia (OR 
0.23, 95% CI 0.14–0.39, p < 0.001) and CAD (OR 
0.32, 95% CI 0.17–0.58, p < 0.001) continued to 
demonstrate an inverse association in predicting 
mortality even after adjusting for all risk factors. 
Gender-specific analysis showed that ventricular 
Table 2. Univariate logistic regression of risk factors predicting mortality.
Variables Total P Males P Females P 
Age 1.03 < 0.001 1.02 0.12 1.04 0.003
Female 1.74 0.009 – – – –
Length of stay 1.02 0.085 1.05 0.005 0.99 0.75
Diabetes mellitus 0.80 0.354 0.50 0.098 1.02 0.96
Hypertension 0.70 0.109 0.80 0.485 0.62 0.10
Hyperlipidemia 0.24 < 0.001 0.17 < 0.001 0.31 < 0.001
Obesity 0.97 0.932 0.38 0.188 1.38 0.38
Coronary artery disease 0.34 < 0.001 0.24 < 0.001 0.48 0.06
Smoking 0.53 0.038 0.55 0.160 0.55 0.18
Heart failure 2.68 < 0.001 1.95 0.073 3.10 < 0.001
Ventricular arrhythmia 6.00 < 0.001 8.02 < 0.001 5.29 < 0.001
Connective tissue disorder 2.69 0.354 – – 3.21 0.29
Table 3. Stepwise multi-model logistic regression of risk factors predicting in-hospital mortality.
Model Total P Males P Females P 
Age
Demographic risk factors
+ Traditional risk factors
+ Non-CV risk factors
1.03
1.04
1.04
0.003
< 0.001
< 0.001
1.02
1.02
1.02
0.171
0.127
0.133
1.04
1.05
1.05
0.009
0.001
0.001
Ventricular arrhythmia
Demographic risk factors
+ Traditional risk factors 
+ Non-CV risk factors
7.39
6.03
6.00
< 0.001
< 0.001
< 0.001
8.54
8.17
8.15
< 0.001
< 0.001
< 0.001
6.27
4.84
4.73
< 0.001
< 0.001
< 0.001
Heart failure
Demographic risk factors
+ Traditional risk factors 
+ Non-CV risk factors
2.17
1.87
1.89
0.002
0.015
0.014
1.56
1.33
1.33
0.299
0.538
0.541
2.76
2.45
2.53
0.001
0.006
0.005
Hyperlipidemia
Demographic risk factors
+ Traditional risk factors 
+ Non-CV risk factors
0.20
0.23
0.23
< 0.001
< 0.001
< 0.001
0.14
0.16
0.16
< 0.001
< 0.001
< 0.001
0.26
0.30
0.30
< 0.001
0.001
0.002
Coronary artery disease
Demographic risk factors
+ Traditional risk factors 
+ Non-CV risk factors
0.24
0.32
0.32
< 0.001
< 0.001
< 0.001
0.17
0.29
0.29
< 0.001
0.007
0.007
0.32
0.40
0.40
0.006
0.030
0.030
CV — cardiovascular; + Step wise addition; Demographic factors: Age, gender and race; Traditional risk factors (or CV risk factors): Diabetes, 
hypertension, obesity, hyperlipidemia, coronary artery disease, smoking and alcohol use; Non-CV risk factors: C tissue disorder
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arrhythmia, hyperlipidemia and CAD predicted 
mortality in fully adjusted models for both men and 
women. However, age (OR 1.04, 95% CI 1.02–1.08, 
p = 0.009) and HF (OR 2.53, 95% CI 1.33–4.80, 
p = 0.005) predicted mortality only in women and 
not in men (Table 3).
Discussion
Our analysis is the largest study to date on CD 
with a prevalence of CD (0.02%) and high mortality 
rate as compared to previous studies [5, 11–13] 
which may be attributed to the large sample size 
and the inclusion of all types of CD. There was an 
increased prevalence in men compared to women, 
whereas other studies demonstrated the opposite. 
This is probably because all types of CD were 
included our analysis, whereas other studies have 
included mostly SCD which is more prevalent in 
younger women with FMD. Our population also had 
a very low number of patients with FMD, which 
occurs more commonly in women with SCD [14]. 
Women had a higher mortality rate (5.5%) than 
males (3.2%), something that has been not been 
described before in a CD population. Not unex-
pectedly, we identified age, ventricular arrhyth-
mia and HF as predictors of increased mortality 
in patients with CD (with advanced female age, 
increased prevalence of ventricular arrhythmia 
and HF among females in our study). However, 
hyperlipidemia and CAD demonstrated an inverse 
association with predicting mortality. This once 
again may be explained by the inclusion of all types 
of CD including atherosclerotic and iatrogenic, 
which may be associated with lower mortality in 
general and also be more likely to include patients 
treated with statins. Treatment with statins may 
be protective and may be used more frequently in 
patients with non-SCD since statins are known to 
reduce peri-procedural myocardial infarction [15], 
diminish the inflammatory response [13, 14, 16] 
and are used for primary [16, 17] and secondary 
prevention [18, 19] of cardiovascular death [20, 21]. 
Future studies may determine their role in all 
comers with CD.
Limitations of the study
Our analysis has several limitations since this 
is an observational study of a large NIS; it includes 
all types of CD where a review of the coronary an-
giograms was not possible. Previous studies have 
focused mostly on SCD, which may be a distinct 
clinical entity more common in women with FMD 
and postpartum status. Also, the very high per-
centage of patients with preexisting CAD makes it 
likely that high numbers of procedure related CD 
were included in our analysis. Since, the diagnosis 
of CD is easier to establish in patients with other-
wise unremarkable coronary arteries (i.e. young 
patients) then in patients with preexisting CAD 
where in many cases additional imaging to coronary 
angiography may be needed to demonstrate a false 
lumen or hematoma (information that is usually not 
available from administrative database like NIS), 
it is essential to have a ICD-9 code for SCD that 
would help physician scientists to separate the 
distinct types of dissection. In addition our study 
excluded patients admitted to the hospital under 
observational status or those who were discharged 
home from the emergency room and those patients 
admitted to any federal hospital (due to absence 
of information recorded in the NIS database). It is 
possible that the actual estimate of patients with 
CD was greater than that recorded in the database, 
thereby underestimating the power of the study. 
Since NIS is an administrative database, diagnostic 
codes are subject to misclassification and there is 
no way to determine if secondary diagnoses rep-
resented an active problem versus past medical 
history. The retrospective design of the study can 
only demonstrate association, and hence causation 
between the predictors of mortality in CD cannot 
be determined. Information from relevant studies, 
such as echocardiograms, coronary angiography, 
computed tomography angiography, single photon 
emission computed tomography, and cardiac bio-
marker data are also not available from the NIS 
database.
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APPENDIX 1. International Classification of Disease, version 9 (ICD-9) codes used for coronary artery 
dissection identification.
Inclusion criteria ICD-9 codes
Coronary artery dissection (any position; primary or all listed diagnosis) 414.12
APPENDIX 2. International Classification of Disease, version 9 (ICD-9) codes used for co-morbidity 
identification.
Co-morbidities* ICD-9 codes
Coronary artery disease 412, 414.xx, V458.1, V458.2
Heart failure 428.xx
Hyperlipidemia 272.xx
Obesity 278.xx, 793.91, V85.21-25, V85.30-45, V85.54
Hypertension 401.x, 402.xx, 403.xx, 404.xx, 405.xx, 437.2
Diabetes mellitus 249.xx, 250.xx, 790.xx, 791.5, 791.6, V458.5, V539.1, V654.6
Ventricular arrhythmias 427, 427.1, 427.4
Alcohol use 303.xx, 305.01, 305.02, 305.03
Smoking 305.1, V15.82
Connective tissue disorder 710.xx
Marfan’s syndrome 759.82
Ehlers-Danlos syndrome 756.83
Fibro muscular dysplasia 447.8
Sarcoidosis 135
Crohn’s disease 555.x
Cocaine use 305.60-63, 304.20-23
Premature labor 644.xx
Rheumatoid arthritis 714.0
Giant cell arteritis 446.5
Takayasu’s disease 446.7
Polyartertis nodosa 446.0
Polycystic kidney disease 753.12, 753.13, 753.14
*Primary and all listed diagnosis
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